|
TABLE OF CONTENTS 1 INTRODUCTION 1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY 1.4 CURRENCY 1.5 STAKEHOLDERS 2 RESEARCH METHODOLOGY 2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.1 PRIMARY DATA
2.1.1.1 Breakdown of primaries
2.1.1.2 Key data from primary sources
2.1.1.3 Key industry insights 2.2 MARKET SIZE ESTIMATION
2.2.1.1 Bottom-up approach
2.2.1.2 Top-down approach 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS 3 EXECUTIVE SUMMARY 3.1 INTRODUCTION 3.2 CURRENT SCENARIO 3.3 FUTURE OUTLOOK 3.4 CONCLUSION 4 PREMIUM INSIGHTS 4.1 ATTRACTIVE OPPORTUNITIES IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 4.2 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET GROWTH RATE, BY TECHNOLOGY AND REGION (2014–2019) 4.3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY AND REGION, 2014 ($MILLION) 4.4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2012–2019 ($MILLION) 5 MARKET OVERVIEW 5.1 INTRODUCTION 5.2 MARKET SEGMENTATION
5.2.1 BY TECHNOLOGY
5.2.2 BY END USER 5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increasing government spending on pharmaceutical R&D in emerging nations
5.3.1.2 Growing food safety concerns
5.3.1.3 Technological advancements in analytical devices
5.3.1.4 Funding sources increase the purchasing power of major research institutions
5.3.2 RESTRAINTS
5.3.2.1 High cost of instruments
5.3.2.2 Presence of alternative technologies
5.3.3 OPPORTUNITIES
5.3.3.1 Emerging markets offering lucrative growth opportunities
5.3.3.2 Growing proteomics market
5.3.3.3 Growing environmental safety concerns
5.3.3.4 Increasing demand from applied markets
5.3.3.5 Opportunity for lab automation solutions in biobank applications
5.3.4 CHALLENGES
5.3.4.1 Extensive requirements in developing chromatography systems that generate pressures of above 20,000 psi
5.3.4.2 Survival of small players in the lab automation market
5.3.4.3 Adoption and implementation of MIQE guidelines for publishing qPCR- and dPCR–based research 6 INDUSTRY INSIGHTS 6.1 INTRODUCTION 6.2 VALUE CHAIN ANALYSIS 6.3 INDUSTRY TRENDS
6.3.1 RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF MINIATURIZED INSTRUMENTS
6.3.2 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES
6.3.3 TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS 6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 THREAT FROM SUBSTITUTES
6.4.3 BARGAINING POWER OF SUPPLIERS
6.4.4 BARGAINING POWER OF BUYERS
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 7 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 7.1 INTRODUCTION 7.2 CHROMATOGRAPHY
7.2.1 DRIVERS
7.2.1.1 New international GMP & GDP certification for pharmaceutical excipients (North America & Europe): EXCiPACT
7.2.1.2 Industry support to research laboratories and academic institutes
7.2.1.3 Rise in government investments in chromatography technologies
7.2.1.4 Increased importance of chromatography tests in drug approvals
7.2.2 RESTRAINT
7.2.2.1 High cost of instruments
7.2.3 CHALLENGE
7.2.3.1 Obtaining identical results from UHPLC after transfer of HPLC to UHPLC
7.2.4 CHROMATOGRAPHY MARKET, BY TYPE
7.2.4.1 Liquid chromatography
7.2.4.2 Gas chromatography
7.2.4.3 Other chromatography techniques
7.2.5 MARKET SHARE ANALYSIS, BY KEY PLAYER 7.3 ELECTROPHORESIS
7.3.1 DRIVERS
7.3.1.1 Preferred technique for fragile molecules and variants
7.3.1.2 Increase in demand for 2D gel electrophoresis
7.3.1.3 Lab-on-a-Chip (LOC) technology
7.3.2 RESTRAINT
7.3.2.1 Alternative technologies provide better results
7.3.3 ELECTROPHORESIS MARKET, BY TYPE
7.3.3.1 Gel electrophoresis
7.3.3.2 Capillary electrophoresis 7.4 DNA SEQUENCERS & AMPLIFIERS
7.4.1 DRIVERS
7.4.1.1 Technological advancements
7.4.1.2 Increasing public and private investments, funds, and grants
7.4.1.3 Rising incidence of infectious diseases and genetic disorders
7.4.2 RESTRAINTS
7.4.2.1 High cost of equipment
7.4.3 DNA SEQUENCERS & AMPLIFIERS MARKET, BY TYPE
7.4.3.1 DNA sequencers
7.4.3.1.1 Market share analysis, by key player
7.4.3.2 DNA amplifiers
7.4.3.2.1 Thermal Cyclers
7.4.3.2.2 Real-time PCR
7.4.3.2.3 Others 7.5 LAB AUTOMATION
7.5.1 DRIVERS
7.5.1.1 Process miniaturization leading to low reagent cost and high productivity
7.5.1.2 Progress in drug discovery and clinical diagnostics
7.5.1.3 Large workforce demand and supply gap
7.5.1.4 Greater productivity and reduction in costs
7.5.1.5 Smaller volumes of samples and reagents required
7.5.2 RESTRAINTS
7.5.2.1 Automation not a priority for small- and medium-sized labs
7.5.2.2 Indefinite data interchange/communication standards
7.5.3 LAB AUTOMATION MARKET, BY TYPE
7.5.3.1 Automatic liquid handling
7.5.3.2 Microplate readers
7.5.3.3 Standalone robots
7.5.3.4 Automated storage and retrieval systems
7.5.3.5 Software and informatics
7.5.3.6 Others
7.5.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 7.6 SPECTROSCOPY
7.6.1 DRIVERS
7.6.1.1 Global alliances amongst leading research institutes to boost drug discovery
7.6.1.2 Atomic absorption spectroscopy to aid in the drug safety process
7.6.1.3 Increasing life science R&D spending
7.6.2 RESTRAINTS
7.6.2.1 High costs restrict purchase
7.6.2.2 Need for skilled professionals
7.6.3 SPECTROSCOPY MARKET, BY TYPE
7.6.3.1 Molecular spectroscopy
7.6.3.1.1 Market share analysis, by key player
7.6.3.2 Atomic spectroscopy
7.6.3.2.1 Market share analysis, by key player
7.6.3.3 Mass spectrometry
7.6.3.3.1 Market share analysis, by key player 7.7 IMMUNOASSAY
7.7.1 DRIVERS
7.7.1.1 Rising incidence of chronic and infectious diseases in emerging economies
7.7.1.2 Increasing number of approvals for immunoassay techniques
7.7.1.3 Advantages such as high sensitivity, low cost, and faster turnaround times
7.7.1.4 Increasing health awareness
7.7.2 RESTRAINTS
7.7.2.1 Low detection restricts adoption of immunoassay tests
7.7.2.2 Pricing pressure for some tests due to competition from lower cost-per-test technologies
7.7.3 IMMUNOASSAY MARKET, BY TYPE
7.7.3.1 Enzyme immunoassay (EIA)
7.7.3.2 Fluorescence immunoassay (FIA)
7.7.3.3 Chemiluminescence immunoassay (CLIA)
7.7.3.4 Radioimmunoassay (RIA)
7.7.3.5 Others
7.7.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 7.8 MICROARRAY
7.8.1 DRIVERS AND OPPORTUNITIES
7.8.1.1 Growth in personalized medicine
7.8.1.2 Technological advances
7.8.1.3 Increasing application areas
7.8.2 RESTRAINT
7.8.2.1 Lack of technical know-how
7.8.3 MICROARRAYS MARKET, BY TYPE
7.8.3.1 DNA microarrays
7.8.3.2 Protein microarrays
7.8.3.3 Tissue microarrays
7.8.3.4 Cell microarrays 7.9 FLOW CYTOMETRY
7.9.1 DRIVERS
7.9.1.1 Technological advancements in flow cytometry instruments
7.9.1.2 Fostering use of flow cytometry techniques in research activities
7.9.1.3 Increasing use of flow cytometry in clinical trials
7.9.1.4 Increasing use of flow cytometry in HIV and cancer research
7.9.1.5 Launch of new reagents for specific applications like diagnostics and drug discovery
7.9.2 RESTRAINTS
7.9.2.1 High cost of instruments
7.9.2.2 Reluctance among researchers in emerging countries to use flow cytometry
7.9.2.3 Lack of awareness and dearth of training
7.9.3 FLOW CYTOMETRY MARKET, BY TYPE
7.9.3.1 Cell-based flow cytometry
7.9.3.2 Bead-based flow cytometry
7.9.3.3 Others
7.9.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 7.10 OTHER INSTRUMENTS
7.10.1 CENTRIFUGES
7.10.2 LABORATORY BALANCES
7.10.2.1 Driver
7.10.2.1.1 Technological advancements in laboratory balances
7.10.2.2 Challenge
7.10.2.2.1 Effect of environmental disturbances
7.10.3 INCUBATORS
7.10.3.1 Drivers
7.10.3.1.1 Genetic engineering will drive the market
7.10.3.1.2 Stem cells and biological therapeutics increase the demand for CO2 incubators
7.10.3.2 Challenge
7.10.3.2.1 Contamination – A Major Concern
7.10.4 FUME HOODS
7.10.4.1 Driver
7.10.4.1.1 Improvements in device structure
7.10.4.2 Restraint
7.10.4.2.1 High electricity consumption 8 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY END USER 8.1 INTRODUCTION 8.2 CHROMATOGRAPHY
8.2.1 PHARMACEUTICAL COMPANIES AND CROS
8.2.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES
8.2.3 ACADEMIC RESEARCH LABORATORIES
8.2.4 AGRICULTURE & FOOD INDUSTRY
8.2.5 ENVIRONMENTAL TESTING
8.2.6 OTHERS 8.3 ELECTROPHORESIS
8.3.1 PHARMACEUTICAL COMPANIES AND CROS
8.3.2 BIOTECHNOLOGY COMPANIES AND LIFE SCIENCE RESEARCH INSTITUTIONS
8.3.3 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES
8.3.4 ACADEMIC INSTITUTIONS
8.3.5 OTHERS 8.4 DNA SEQUENCERS & AMPLIFIERS
8.4.1 PHARMA & BIOTECH COMPANIES AND CROS
8.4.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
8.4.3 HOSPITALS AND DIAGNOSTIC CENTERS
8.4.4 FORENSIC SCIENCE LABORATORIES 8.5 LAB AUTOMATION
8.5.1 PHARMA & BIOTECH COMPANIES AND CROS
8.5.2 HOSPITALS AND PRIVATE LABS
8.5.3 RESEARCH INSTITUTIONS
8.5.4 ACADEMIC INSTITUTIONS 8.6 SPECTROSCOPY
8.6.1 PHARMACEUTICAL COMPANIES AND CROS
8.6.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES
8.6.3 ENVIRONMENTAL TESTING
8.6.4 FOOD AND BEVERAGE INDUSTRY
8.6.5 INDUSTRIAL CHEMISTRY
8.6.6 ACADEMIC INSTITUTIONS
8.6.7 OTHERS 8.7 IMMUNOASSAYS
8.7.1 HOSPITALS (PRIVATE/PUBLIC)
8.7.2 LABORATORIES (PRIVATE/PUBLIC)
8.7.3 PHARMACEUTICAL & BIOTECH COMPANIES AND CROS
8.7.4 ACADEMIC INSTITUTIONS
8.7.5 OTHERS 8.8 MICROARRAYS
8.8.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY
8.8.2 RESEARCH LABORATORIES
8.8.3 DIAGNOSTIC LABORATORIES
8.8.4 ACADEMIC INSTITUTIONS
8.8.5 OTHERS 8.9 FLOW CYTOMETRY
8.9.1 COMMERCIAL ORGANIZATIONS
8.9.2 ACADEMIC INSTITUTIONS
8.9.3 HOSPITALS
8.9.4 CLINICAL TESTING LABS
8.9.5 MEDICAL SCHOOLS 8.10 OTHER INSTRUMENTATION
8.10.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES AND CROS
8.10.2 RESEARCH LABORATORIES
8.10.3 ACADEMIC INSTITUTIONS
8.10.4 OTHERS 9 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY REGION 9.1 INTRODUCTION 9.2 NORTH AMERICA
9.2.1 FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES
9.2.2 DRUG DEVELOPMENT REGULATIONS IN NORTH AMERICA
9.2.3 GROWING METABOLOMICS RESEARCH IN THE U.S.
9.2.4 CONFERENCES, DISCUSSIONS, SYMPOSIUMS, & SEMINARS
9.2.5 RISING PREVALENCE OF CHRONIC DISEASES AND AGING POPULATION 9.3 EUROPE
9.3.1 DIRECT AND INDIRECT FINANCIAL INVESTMENTS IN ANALYTICAL INSTRUMENTS
9.3.2 STRATEGIC ALLIANCES IN EUROPE TO TRIGGER THE GROWTH OF DRUG DISCOVERY
9.3.3 BURGEONING GROWTH OF THE EUROPEAN BIOSIMILARS MARKET
9.3.4 CONFERENCES AND SYMPOSIA
9.3.5 DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA 9.4 ASIA-PACIFIC
9.4.1 STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES
9.4.2 GROWING PHARMACEUTICAL INDUSTRY IN INDIA AND CHINA
9.4.3 EXTENSIVE CROP RESEARCH IN ASIA
9.4.4 GOVERNMENT INVESTMENTS IN THE BIOMEDICAL INDUSTRY IN CHINA
9.4.5 INFRASTRUCTURAL DEVELOPMENT IN VIETNAM
9.4.6 SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE AND CHEMICAL INSTRUMENTATION
9.4.7 CONFERENCES, EXHIBITIONS, & MEETINGS ON ANALYTICAL INSTRUMENTS 9.5 REST OF THE WORLD
9.5.1 FLOURISHING BIOTECHNOLOGY & PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO
9.5.2 INCREASING R&D FUNDING IN THE LATIN AMERICAN REGION
9.5.3 HIGH PREVALENCE OF HIV IN AFRICAN REGION IS LIKELY TO OPEN NEW GROWTH POTENTIAL FOR THE LAB AUTOMATION, IMMUNOASSAY, AND PCR MARKETS 10 COMPETITIVE LANDSCAPE 10.1 INTRODUCTION
10.1.1 NEW PRODUCT LAUNCHES
10.1.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.1.3 EXPANSIONS
10.1.4 ACQUISITIONS
10.1.5 OTHER DEVELOPMENTS 11 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)* 11.1 INTRODUCTION 11.2 AGILENT TECHNOLOGIES, INC. 11.3 BECTON, DICKINSON AND COMPANY 11.4 BIO-RAD LABORATORIES, INC. 11.5 BRUKER CORPORATION 11.6 DANAHER CORPORATION 11.7 F. HOFFMANN-LA ROCHE LTD. 11.8 PERKINELMER, INC. 11.9 SHIMADZU CORPORATION 11.10 THERMO FISHER SCIENTIFIC, INC. 11.11 WATERS CORPORATION *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies. 12 APPENDIX 12.1 INSIGHTS OF INDUSTRY EXPERTS 12.2 DISCUSSION GUIDE 12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 12.4 AVAILABLE CUSTOMIZATIONS 12.5 RELATED REPORTS
LIST OF TABLES
TABLE 1 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 2 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 3 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 4 LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 5 GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 6 OTHER CHROMATOGRAPHY TECHNIQUES MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 7 GLOBAL ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 8 ELECTROPHORESIS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 9 GEL ELECTROPHORESIS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 10 CAPILLARY ELECTROPHORESIS MARKET SIZE, BY REGION, 2012- 2019 ($MILLION)
TABLE 11 GLOBAL DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
TABLE 12 GLOBAL DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 13 DNA SEQUENCERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 14 GLOBAL DNA AMPLIFIERS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
TABLE 15 DNA AMPLIFIERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 16 THERMO CYCLERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 17 REAL-TIME PCR MARKET SIZE, BY REGION, 2012- 2019 ($MILLION)
TABLE 18 OTHER AMPLIFIERS MARKET SIZE, BY REGION, 2012- 2019 ($MILLION)
TABLE 19 GLOBAL LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
TABLE 20 LAB AUTOMATION MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 21 AUTOMATED LIQUID HANDLING MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 22 MICROPLATE READERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 23 STANDALONE ROBOTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 24 AUTOMATED STORAGE AND RETRIEVAL SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 25 SOFTWARE AND INFORMATICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 26 OTHER LAB AUTOMATION EQUIPMENT AND SOFTWARE MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 27 GLOBAL SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 28 SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 29 MOLECULAR SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 30 ATOMIC SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 31 MASS SPECTROMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 32 IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 33 IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 34 ENZYME IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 35 FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 36 CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 37 RADIOIMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 38 OTHER IMMUNOASSAYS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 39 GLOBAL MICROARRAY MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
TABLE 40 MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 41 DNA MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 42 PROTEIN MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 43 TISSUE MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 44 CELL MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 45 GLOBAL FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 46 FLOW CYTOMETER ARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 47 CELL-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 48 BEAD-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 49 OTHER FLOW CYTOMETRY TECHNOLOGIES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 50 GLOBAL OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
TABLE 51 OTHER INSTRUMENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 52 CENTRIFUGES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 53 LABORATORY BALANCES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 54 INCUBATORS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 55 FUME HOODS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 56 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 57 GLOBAL ELECTROPHORESIS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 58 GLOBAL DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 59 GLOBAL LAB AUTOMATION MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 60 GLOBAL SPECTROSCOPY MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 61 GLOBAL IMMUNOASSAYS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 62 GLOBAL MICROARRAYS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 63 GLOBAL FLOW CYTOMETRY MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 64 GLOBAL OTHER INSTRUMENTATION MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 65 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 66 NORTH AMERICA: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 67 NORTH AMERICA: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 68 NORTH AMERICA: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 69 NORTH AMERICA: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 70 NORTH AMERICA: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
TABLE 71 NORTH AMERICA: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 72 NORTH AMERICA: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 73 NORTH AMERICA: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 74 NORTH AMERICA: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 75 NORTH AMERICA: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 76 EUROPE: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 77 EUROPE: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 78 EUROPE: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 79 EUROPE: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 80 EUROPE: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
TABLE 81 EUROPE: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 82 EUROPE: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 83 EUROPE: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 84 EUROPE: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 85 EUROPE: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 86 ASIA-PACIFIC: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 87 ASIA-PACIFIC: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 88 ASIA-PACIFIC: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 89 ASIA-PACIFIC: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 90 ASIA-PACIFIC: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
TABLE 91 ASIA-PACIFIC: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 92 ASIA-PACIFIC: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 93 ASIA-PACIFIC: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 94 ASIA-PACIFIC: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 95 ASIA-PACIFIC: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 96 ROW: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 97 ROW: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 98 ROW: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 99 ROW: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 100 ROW: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
TABLE 101 ROW: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 102 ROW: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 103 ROW: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 104 ROW: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 105 ROW: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 106 TOP 5 NEW PRODUCT LAUNCHES, 2012–2014
TABLE 107 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2014
TABLE 108 TOP 5 GEOGRAPHICAL EXPANSIONS, 2012–2014
TABLE 109 TOP 5 ACQUISITIONS, 2012–2014
TABLE 110 TOP 5 OTHER DEVELOPMENTS, 2012–2014
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 28
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
FIGURE 3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: BOTTOM-UP APPROACH
FIGURE 4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: TOP-DOWN APPROACH
FIGURE 5 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: DATA TRIANGULATION
FIGURE 6 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, 2014 ($MILLION)
FIGURE 7 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2014 VS. 2019
FIGURE 8 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY REGION, 2014 ($MILLION)
FIGURE 9 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES TO PLAYERS IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET
FIGURE 10 ASIA-PACIFIC DNA SEQUENCERS AND AMPLIFIERS MARKET OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR PLAYERS
FIGURE 11 SPECTROSCOPY DOMINATES THE GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET ACROSS ALL GEOGRAPHIC REGIONS
FIGURE 12 SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET IN 2019
FIGURE 13 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SEGMENTATION
FIGURE 14 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY
FIGURE 15 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SEGMENTATION, BY END USER
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 17 INCREASING GOVERNMENT SPENDING ON PHARMACEUTICAL R&D IN EMERGING NATIONS IS PROPELLING THE MARKET GROWTH
FIGURE 18 HIGH COST OF TECHNOLOGICALLY ADVANCED INSTRUMENTS LIMITS THEIR ADOPTION AMONG LOW-BUDGET END USERS
FIGURE 19 EMERGING COUNTRIES ARE OFFERING LUCRATIVE GROWTH OPPORTUNITIES FOR MARKET PLAYERS
FIGURE 20 VALUE CHAIN OF LIFE SCIENCE AND CHEMICAL INSTRUMENTATION INDUSTRY
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS
FIGURE 22 LIQUID CHROMATOGRAPHY SEGMENT ACCOUNTED FOR THE LION’S SHARE OF THE GLOBAL CHROMATOGRAPHY MARKET IN 2014
FIGURE 23 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 24 GEL ELECTROPHORESIS HELD THE LARGEST SHARE OF THE GLOBAL ELECTROPHORESIS MARKET IN 2014
FIGURE 25 DNA SEQUENCERS AND AMPLIFIERS MARKET IS POISED TO GROW AT A DOUBLE-DIGIT CAGR FROM 2014 TO 2019
FIGURE 26 BURGEONING PREVALENCE OF HIV WORLDWIDE WILL BOOST THE ADOPTION OF PCR
FIGURE 27 GLOBAL DNA SEQUENCERS MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 28 MICROPLATE READERS ARE THE FASTEST-GROWING SEGMENT IN THE GLOBAL LAB AUTOMATION MARKET
FIGURE 29 INFORMATION FLOW PYRAMID
FIGURE 30 GLOBAL LAB AUTOMATION MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 31 MOLECULAR SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL SPECTROSCOPY MARKET IN 2019
FIGURE 32 GLOBAL MOLECULAR SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 33 GLOBAL ATOMIC SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 34 GLOBAL MASS SPECTROMETRY MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 35 ENZYME IMMUNOASSAYS SEGMENT DOMINATED THE GLOBAL IMMUNOASSAY MARKET IN 2014
FIGURE 36 GLOBAL PREVALENCE OF CANCER
FIGURE 37 GLOBAL DISTRIBUTION OF CARDIOVASCULAR MORTALITY RATES AMONG MALES, 2011
FIGURE 38 GLOBAL DISTRIBUTION OF CARDIOVASCULAR MORTALITY RATES AMONG FEMALES, 2011
FIGURE 39 GLOBAL IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 40 OVER 50% OF THE MICROARRAY MARKET WAS DOMINATED BY DNA MICROARRAYS IN 2014
FIGURE 41 CELL-BASED FLOW CYTOMETRY SEGMENT DOMINATES THE FLOW CYTOMETRY MARKET
FIGURE 42 GLOBAL FLOW CYTOMETRY MARKET SHARE, BY KEY PLAYER, 2014
FIGURE 43 PHARMACEUTICAL COMPANIES AND CROS HOLD THE LARGEST SHARE OF CHROMATOGRAPHY END USERS MARKET
FIGURE 44 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES ARE THE MAJOR END USERS OF ELECTROPHORESIS DEVICES
FIGURE 45 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE FASTEST-GROWING END-USER SEGMENT OF THE DNA SEQUENCERS AND AMPLIFIERS MARKET
FIGURE 46 THE ADOPTION OF LAB AUTOMATION SOLUTIONS IS INCREASING RAPIDLY AMONG RESEARCH INSTITUTIONS
FIGURE 47 PHARMACEUTICAL COMPANIES AND CROS COMMAND THE LARGEST SHARE OF THE GLOBAL SPECTROSCOPY END USERS MARKET
FIGURE 48 HOSPITALS ARE THE MAJOR END USERS OF THE IMMUNOASSAYS MARKET
FIGURE 49 PHARMA AND BIOPHARMA INDUSTRIES DOMINATE THE MICROARRAY INSTRUMENTATION END USERS MARKET
FIGURE 50 CLINICAL TESTING LABS IS THE FASTEST-GROWING SEGMENT OF THE FLOW CYTOMETRY END USERS MARKET
FIGURE 51 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
FIGURE 52 AVAILABILITY OF LIFE SCIENCE RESEARCH FUNDING IS DRIVING THE MARKET GROWTH
FIGURE 53 EUROPEAN LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SNAPSHOT (2014-2019): DIRECT AND INDIRECT INVESTMENTS IN ANALYTICAL INSTRUMENTS ARE DRIVING THE MARKET GROWTH
FIGURE 54 ASIA-PACIFIC LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SNAPSHOT (2014-2019): KEY PLAYERS ARE STRATEGICALLY EXPANDING THEIR PRESENCE IN THIS EMERGING MARKET
FIGURE 55 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY IN 2014
FIGURE 56 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES IS THE KEY STRATEGY
FIGURE 57 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS
FIGURE 58 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 59 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 60 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 61 BRUKER CORPORATION: COMPANY SNAPSHOT
FIGURE 62 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 63 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 64 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 65 SHIMADZU CORPORATION: COMPANY SNAPSHOT
FIGURE 66 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 67 WATERS CORPORATION: COMPANY SNAPSHOT
|
현재위치 : 
